Mild to moderate active Crohn's Disease involving the ileum and or ascending colon:
9 mg orally once daily in the morning for up to 8 weeks. Treatment can be tapered to 6 mg daily for 2 weeks prior to complete cessation. For recurring episodes of active Crohn's Disease, repeated eight-week courses can be given. Following 8 week course(s) of treatment for active disease and once the patient's symptoms are controlled, 6 mg once daily is recommended for maintenance of clinical remission up to 3 months.